Investigation of pathways for the low-pH conformational transition in influenza hemagglutinin

Biophysical Journal

Volumn 84, Issue 3, 2003, Pages 1926-1939

  Madhusoodanan, M ^a   Lazaridis, Themis ^a  

^a CITY COLLEGE OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; PEPTIDE; PROTEIN PRECURSOR;

ARTICLE; CONFORMATIONAL TRANSITION; DISSOCIATION; ENERGY; ENERGY TRANSFER; INFLUENZA VIRUS; MEMBRANE FUSION; MODEL; MOLECULAR DYNAMICS; PH; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN STRUCTURE; SIMULATION; VIRUS ENVELOPE;

INFLUENZA VIRUS;

EID: 0037340698     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(03)75001-2     Document Type: Article

References (64)

1. Apostolakis, J., P. Ferrara, and A. Caflisch. 1999. Calculation of conformational transitions and barriers in solvated systems: application to the alanine dipeptide in water. J. Chem. Phys. 110:2099-2108.
2. Bechor, D., and N. Ben-Tal. 2001. Implicit solvent model studies of the interactions of the influenza hemagglutinin fusion peptide with lipid bilayers. Biophys. J. 80:643-655.
3. Bentz, J. 1992. Intermediates and kinetics of membrane fusion. Biophys. J. 63:448-459.
4. Bentz, J. 2000. Membrane fusion mediated by coiled coils: a hypothesis. Biophys. J. 78:886-900.
5. Bentz, J., H. Ellens, and D. Alford. 1990. An architecture for the fusion site of influenza hemagglutinin. FEBS Lett. 276:1-5.
6. Bockmann, R. A., and H. Grubmuller. 2002. Nanoseconds MD simulation of primary mechanical energy transfer steps in F1-ATP synthase. Nature Str. Biol. 9:198-202.
7. Bonnafous, P., and T. Stegmann. 2000. Membrane perturbation and fusion pore formation in influenza hemagglutinin-mediated membrane fusion. J. Biol. Chem. 275:6160-6166.
8. Böttcher, C., K. Ludwig, A. Herrmann, M. V. Heel, and H. Stark. 1999. Structure of influenza hemagglutinin at neutral and at fusogenic pH by electron cryo-microscopy. FEBS Lett. 463:255-259.
9. Bradshaw, J. P., M. J. M. Darkes, T. A. Harroun, J. Katsaras, and R. M. Epand. 2000. Oblique membrane insertion of viral fusion peptide probed by neutron diffraction. Biochemistry. 39:6581-6585.
10. Brasseur, R., T. Pillot, L. Lins, J. Vandekerckhove, and M. Rosseneu. 1997. Peptides in membranes: tipping the balance of membrane stability. TIBS. 22:167-171.
11. Brooks, B. R., R. E. Bruccoleri, B. D. Olafson, D. J. States, S. Swaminathan, and M. Karplus. 1983. CHARMM: a program for macromolecular energy minimization and dynamics calculations. J. Comput. Chem. 4:187-217.
12. Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley. 1994. Structure of influenza hemagglutinin at the pH of membrane fusion. Nature. 371:37-43.
13. Carr, C. M., C. Chaudhry, and P. S. Kim. 1997. Influenza hemagglutinin is spring-loaded by a metastable native configuration. Proc. Natl. Acad. Sci. USA. 94:14306-14313.
14. Carr, C. M., and P. S. Kim. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell. 73:823-832.
15. Chen, J., K. H. Lee, D. A. Steinhauer, D. J. Stevens, J. J. Skehel, and D. C. Wiley. 1998. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell. 95:409-417.
16. 2 subunit to form an N-cap that terminates the triple-stranded coiled coil. Proc. Natl. Acad. Sci. USA. 96:8967-8972.
17. 2) folds in Escherichia coli into the low-pH-induced conformation. Proc. Natl. Acad. Sci. USA. 92:12205-12209.
18. Chemomordik, L. V., E. Leikina, V. Frolov, P. Bronk, and J. Zimmerberg. 1998. The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation. J. Cell Biol. 140:1369-1382.
19. Cohen, F. S., and G. B. Melikyan. 2001. Implications of a fusion peptide structure. Nat. Struct. Biol. 8:653-655.
20. Daniels, R. S., A. R. Douglas, J. J. Skehel, and D. C. Wiley. 1983. Analyses of the antigenicity of influenza hemagglutinin at the pH optimum for virus-mediated membrane fusion. J. Gen. Virol. 64:1657-1662.
21. Diaz, J., J. Wroblowski, J. Schlitter, and Y. Engelborghs. 1997. Calculation of pathways for the conformational transition between the GTP- and GDP-bound states of the HA-ras-p21 protein: calculations with explicit solvent simulations and comparison with calculations in vacuum. Proteins. 28:434-451.
22. Dominy, B. N., and C. L. Brooks, III. 1999. Development of a generalized Born model parameterization for proteins and nucleic acids. J. Phys. Chem. B. 103:3765-3773.
23. Doms, R. W., A. Helenius, and J. White. 1985. Membrane fusion activity of influenza virus hemagglutinin. J. Biol. Chem. 260:2973-2981.
24. Durell, S. R., I. Martin, J. M. Ruysschaert, Y. Shai, and R. Blumenthal. 1997. What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion. Mol. Membr. Biol. 14:97-112.
25. Eckert, D. M., and P. S. Kim. 2001. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70:777-810.
26. Ferrara, P., J. Apostolakis, and A. Caflisch. 2000a. Computer simulations of protein folding by targeted molecular dynamics. Proteins. 39:252-260.
27. Ferrara, P., J. Apostolakis, and A. Caflisch. 2000b. Targeted molecular dynamics simulations of protein unfolding. J. Phys. Chem. B. 104:4511-4518.
28. Gething, M. J., R. W. Doms, D. York, and J. White. 1986. Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J. Cell Biol. 102:11-23.
29. Godley, L., J. Pfeifer, D. Steinhauer, B. Ely, G. Shaw, R. Kaufmann, E. Suchanek, C. Pabo, J. J. Skehel, D. C. Wiley, and S. Wharton. 1992. Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity. Cell. 68:635-645.
30. Han, X., J. H. Bushweller, D. S. Cafiso, and L. K. Tamm. 2001. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat. Struct. Biol. 8:715-720.
31. Han, X., and L. K. Tamm. 2000. A host-guest system to study structure-function relationships of membrane fusion peptides. Proc. Natl. Acad. Sci. USA. 97:13097-13102.
32. Hernandez, L. D., L. R. Hoffman, T. G. Wolfsberg, and J. M. White. 1996. Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev. Biol. 12:627-661.
33. Hughson, F. M. 1997. Enveloped viruses: a common mode of membrane fusion? Curr. Biol. 7:R565-R569.
34. Kemble, G. W., D. L. Bodian, J. Rose, I. A. Wilson, and J. M. White. 1992. Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin. J. Virol. 66:4940-4950.
35. Koradi, R., M. Billeter, and K. Wüthrich. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:51-55.
36. Kozlov, M. M., and L. V. Chemomordik. 1998. A mechanism of protein-mediated fusion: coupling between refolding of the influenza hemagglutinin and lipid rearrangements. Biophys. J. 75:1384-1396.
37. Krumbiegel, M., A. Herrmann, and R. Blumenthal. 1994. Kinetics of the low pH-induced conformational changes and fusogenic activity of influenza hemagglutinin. Biophys. J. 67:2355-2360.
38. Lazaridis, T., and M. Karplus. 1999. Effective energy function for proteins in solution. Proteins. 35:133-152.
39. Lazaridis, T., and M. Karplus. 2001. Microscopic basis of macromolecular thermodynamics. In Thermodynamics in Biology. E. DiCera, editor. Oxford University Press, Oxford. pp3-48.
40. Lear, J. D., and W. F. DeGrado. 1987. Membrane binding and conformational properties of peptides representing the NH2 terminus of influenza HA2. J. Biol. Chem. 262:6500-6505.
41. Ma, J., T. C. Flynn, Q. Cui, A. G. W. Leslie, J. E. Walker, and M. Karplus. 2002. A dynamic analysis of the rotation mechanism for conformational change in F1-ATPase. Structure. 10:921-931.
42. Ma, J., and M. Karplus. 1997. Molecular switch in signal transduction: reaction paths of the conformational changes in ras p21. Proc. Natl. Acad. Sci. USA. 94:11905-11910.
43. Macosko, J. C., C.-H. Kim, and Y.-K. Shin. 1997. The membrane topology of the fusion peptide region of influenza hemagglutinin determined by spin-labeling EPR. J. Mol. Biol. 267:1139-1148.
44. Melikyan, G. B., R. M. Markosyan, H. Hemmati, M. K. Delmedico, D. M. Lambert, and F. S. Cohen. 2000. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J. Cell Biol. 151:413-423.
45. Neria, E., S. Fischer, and M. Karplus. 1996. Simulation of activation free energies in molecular systems. J. Chem. Phys. 105:1902-1921.
46. Ponder, J. W. 2001. TINKER, Version 3.9. Software Tools for Molecular Design.
47. Qiao, H., R. T. Armstrong, G. B. Melikyan, F. S. Cohen, and J. M. White. 1999. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol. Biol. Cell. 10:2759-2769.
48. Remeta, D. P., M. Krumbiegel, C. A. S. A. Minetti, A. Puri, A. Ginsbur, and R. Blumenthal. 2002. Acid-induced changes in thermal stability and fusion activity of influenza hemagglutinin. Biochemistry. 41:2044-2054.
49. Ruigrok, R. W. H., A. Aitken, L. J. Calder, S. R. Martin, J. J. Skehel, S. A. Wharton, W. Weis, and D. C. Wiley. 1988. Studies on the structure of the influenza virus hemagglutinin at the pH of membrane fusion. J. Gen. Virol. 69:2785-2795.
50. Ruigrok, R. W. H., N. G. Wrigley, L. J. Calder, S. Cusack, S. A. Wharton, E. B. Brown, and J. J. Skehel. 1986. Electron microscopy of the low pH structure of influenza virus hemagglutinin. EMBO J. 5:41-49.
51. Schlitter, J., M. Engels, P. Krüger, E. Jacoby, and A. Wollmer. 1993. Targeted molecular dynamics simulation of conformational change application to the T → R transition in insulin. Mol. Simul. 10:291-308.
52. Shangguan, T., D. P. Siegel, J. D. Lear, P. H. Axelsen, D. Alford, and J. Bentz. 1998. Morphological changes and fusogenic activity of influenza virus hemagglutinin. Biophys. J. 74:54-62.
53. Skehel, J. J., P. M. Bayley, E. B. Brown, S. R. Martin, M. D. Waterfield, J. M. White, I. A. Wilson, and D. C. Wiley. 1982. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc. Natl. Acad. Sci. USA. 79:968-972.
54. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569.
55. Stegmann, T., J. M. White, and A. Helenius. 1990. Intermediates in influenza induced membrane fusion. EMBO J. 9:4231-4241.
56. Webster, R. G., L. E. Brown, and D. C. Jackson. 1983. Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH. Virology. 126:587-599.
57. Wharton, S. A., R. W. H. Ruigrok, S. R. Martin, J. J. Skehel, P. M. Bayley, W. Weis, and D. C. Wiley. 1988. Conformational aspects of the acid-induced fusion mechanism of influenza virus hemagglutinin. J. Biol. Chem. 263:4474-4480.
58. White, J. M. 1992. Membrane fusion. Science. 258:917-924.
59. White, J. M., and I. A. Wilson. 1987. Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J. Cell Biol. 105:2887-2896.
60. Wiley, D. C., and J. J. Skehel. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56:365-394.
61. Wiley, D. C., I. A. Wilson, and J. J. Skehel. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza hemagglutinin and their involvement in antigenic variation. Nature. 289:373-378.
62. Wilson, I. A., J. J. Skehel, and D. C. Wiley. 1981. Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature. 289:366-373.
63. Yang, L., W. A. Beard, S. H. Wilson, S. Broyde, and T. Schlick. 2002. Polymerase β simulations suggest that Arg258 rotation is a slow step rather than large subdomain motions Per Se. J. Mol. Biol. 317:651-671.
64. Yewdell, J. W., W. Gerhard, and T. Bachi. 1983. Monoclonal anti-hemagglutinin antibodies detect irreversible antigenic alterations that coincide with the acid activation of influenza virus A/PR/834-mediated hemolysis. J. Virol. 48:239-248.